IL2 and cancer: Now, recent studies have shown that continuous exposure of CD8+ T cells to high levels of IL-2 leads to lymphocyte exhaustion, losing reactivity to cancer cells, and therefore being unable to exert their cytotoxic function, eventually leading to their death [44,45,46].